Literature DB >> 312296

In vivo inactivation of erythrocyte S-adenosylhomocysteine hydrolase by 2'-deoxyadenosine in adenosine deaminase-deficient patients.

M S Hershfield, N M Kredich, D R Ownby, H Ownby, R Buckley.   

Abstract

The cytotoxic nucleoside 2'-deoxyadenosine is excreted in excessive amounts by individuals with genetic deficiency of adenosine deaminase, and may be in part responsible for the severe combined immune dysfunction from which they suffer. Earlier studies from this laboratory showed that 2'-deoxyadenosine causes the irreversible inactivation of the enzyme S-adenosylhomocysteine hydrolase by an active site-directed, "suicide-like" process. In this communication we have demonstrated similar inactivation of S-adenosylhomocysteine hydrolase in hemolysate and in intact erythrocytes, as well as a striking deficiency of S-adenosylhomocysteine hydrolase activity in the erythrocytes of three adenosine deaminase-deficient patients. In vivo suicide-like inactivation of S-adenosylhomocysteine hydrolase by 2'-deoxyadenosine may contribute to the cytotoxicity of 2'-deoxyadenosine and to the immune dysfunction in adenosine deaminase deficiency.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 312296      PMCID: PMC372019          DOI: 10.1172/JCI109367

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  15 in total

1.  The enzymatic synthesis of S-adenosyl-L-homocysteine from adenosine and homocysteine.

Authors:  G DE LA HABA; G L CANTONI
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Deoxyadenosine metabolism and cytotoxicity in cultured mouse T lymphoma cells: a model for immunodeficiency disease.

Authors:  B Ullman; L J Gudas; A Cohen; D W Martin
Journal:  Cell       Date:  1978-06       Impact factor: 41.582

Review 4.  Recent developments in suicide substrates and other active site-directed inactivating agents of specific target enzymes.

Authors:  C Walsh
Journal:  Horiz Biochem Biophys       Date:  1977

5.  Apparent suicide inactivation of human lymphoblast S-adenosylhomocysteine hydrolase by 2'-deoxyadenosine and adenine arabinoside. A basis for direct toxic effects of analogs of adenosine.

Authors:  M S Hershfield
Journal:  J Biol Chem       Date:  1979-01-10       Impact factor: 5.157

6.  Overproduction of adenine deoxynucleosides and deoxynucletides in adenosine deaminase deficiency with severe combined immunodeficiency disease.

Authors:  J Donofrio; M S Coleman; J J Hutton; A Daoud; B Lampkin; J Dyminski
Journal:  J Clin Invest       Date:  1978-10       Impact factor: 14.808

7.  Identification and quantitation of adenine deoxynucleotides in erythrocytes of a patient with adenosine deaminase deficiency and severe combined immunodeficiency.

Authors:  M S Coleman; J Donofrio; J J Hutton; L Hahn; A Daoud; B Lampkin; J Dyminski
Journal:  J Biol Chem       Date:  1978-03-10       Impact factor: 5.157

8.  Adenine and adenosine are toxic to human lymphoblast mutants defective in purine salvage enzymes.

Authors:  M S Hershfield; F F Snyder; J E Seegmiller
Journal:  Science       Date:  1977-09-23       Impact factor: 47.728

9.  Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency.

Authors:  A Cohen; R Hirschhorn; S D Horowitz; A Rubinstein; S H Polmar; R Hong; D W Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

10.  S-adenosylhomocysteine hydrolase is an adenosine-binding protein: a target for adenosine toxicity.

Authors:  M S Hershfield; N M Krodich
Journal:  Science       Date:  1978-11-17       Impact factor: 47.728

View more
  37 in total

1.  Adenosine deaminase deficiency increases thymic apoptosis and causes defective T cell receptor signaling.

Authors:  S G Apasov; M R Blackburn; R E Kellems; P T Smith; M V Sitkovsky
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

2.  S-Adenosylhomocysteine hydrolase deficiency: a second patient, the younger brother of the index patient, and outcomes during therapy.

Authors:  I Barić; M Cuk; K Fumić; O Vugrek; R H Allen; B Glenn; M Maradin; L Pazanin; I Pogribny; M Rados; V Sarnavka; A Schulze; S Stabler; C Wagner; S H Zeisel; S H Mudd
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

3.  Insights into thymic purine metabolism and adenosine deaminase deficiency revealed by transgenic mice overexpressing ecto-5'-nucleotidase (CD73).

Authors:  R Resta; S W Hooker; A B Laurent; S M Jamshedur Rahman; M Franklin; T B Knudsen; N L Nadon; L F Thompson
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

4.  S-adenosylhomocysteine hydrolase deficiency in a 26-year-old man.

Authors:  N R M Buist; B Glenn; O Vugrek; C Wagner; S Stabler; R H Allen; I Pogribny; A Schulze; S H Zeisel; I Barić; S H Mudd
Journal:  J Inherit Metab Dis       Date:  2006-05-30       Impact factor: 4.982

5.  S-Adenosylhomocysteine hydrolase from human placenta. Affinity purification and characterization.

Authors:  M S Hershfield; V N Aiyar; R Premakumar; W C Small
Journal:  Biochem J       Date:  1985-08-15       Impact factor: 3.857

6.  Adenosine deaminase and 5'nucleotidase activities in peripheral blood T cells of multiple sclerosis patients.

Authors:  S Vivekanandhan; C C Soundararajan; M Tripathi; M C Maheshwari
Journal:  Neurochem Res       Date:  2005-04       Impact factor: 3.996

7.  Resistance of an adenosine kinase-deficient human lymphoblastoid cell line to effects of deoxyadenosine on growth, S-adenosylhomocysteine hydrolase inactivation, and dATP accumulation.

Authors:  M S Hershfield; N M Kredich
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

8.  Modulation of cyclic AMP metabolism by S-adenosylhomocysteine and S-3-deazaadenosylhomocysteine in mouse lymphocytes.

Authors:  T P Zimmerman; C J Schmitges; G Wolberg; R D Deeprose; G S Duncan; P Cuatrecasas; G B Elion
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

9.  Novel splicing, missense, and deletion mutations in seven adenosine deaminase-deficient patients with late/delayed onset of combined immunodeficiency disease. Contribution of genotype to phenotype.

Authors:  I Santisteban; F X Arredondo-Vega; S Kelly; A Mary; A Fischer; D S Hummell; A Lawton; R U Sorensen; E R Stiehm; L Uribe
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

10.  Inactivation of liver S-adenosylhomocysteine hydrolase in vitro of rats treated with erythro-9-(2-hydroxynon-3-yl)adenine.

Authors:  E O Kajander
Journal:  Biochem J       Date:  1982-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.